Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Announcement & Circular
Stock Information
02186.HK
1.95 -0.04  (-2.01%)
TradingVolume：2070.4
10-07
2015
THE FDA CONFIRMED NO ADDITIONAL CLINICAL TRIALS ARE NEEDED FOR THE NDA SUBMISSION FOR LY03004 IN THE U.S.
Publisher：
10-02
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2015
Publisher：
09-30
2015
DISCLOSEABLE TRANSACTION - SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS
Publisher：
09-29
2015
Interim Report 2015
Publisher：
09-07
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2015
Publisher：
08-30
2015
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2015
Publisher：
08-18
2015
NOTICE OF BOARD MEETING
Publisher：
08-12
2015
ANNOUNCEMENT - COMPLETION OF PHASE 1 CLINICAL STUDIES OF ANSOFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS (LY03005) IN THE U.S.
Publisher：
08-03
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2015
Publisher：
07-06
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2015
Publisher：
First
45
46
47
48
49
Last
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Stock Information
02186.HK
TradingVolume：2070.4
1.95
-0.04  (-2.01%)
Announcement & Circular
10-07
2015
THE FDA CONFIRMED NO ADDITIONAL CLINICAL TRIALS ARE NEEDED FOR THE NDA SUBMISSION FOR LY03004 IN THE U.S.
10-02
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2015
09-30
2015
DISCLOSEABLE TRANSACTION - SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS
09-29
2015
Interim Report 2015
09-07
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2015
08-30
2015
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2015
08-18
2015
NOTICE OF BOARD MEETING
08-12
2015
ANNOUNCEMENT - COMPLETION OF PHASE 1 CLINICAL STUDIES OF ANSOFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS (LY03005) IN THE U.S.
08-03
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2015
07-06
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2015
First
45
46
47
48
49
Last